Browsing by Author "Kumarasamy, Nagalingeswaran"
Now showing items 16-35 of 39
-
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
Palumbo, Philip J. et al. | Date Issued: 2018 -
HIV prevention in clinical care settings 2014 recommendations of the international antiviral society– USA panel
Marrazzo, Jeanne M. et al. | Date Issued: 2014 -
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries
Avila, Dorita et al. | Date Issued: 2014 -
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study
Folschweiller, Nicolas et al. | Date Issued: 2020 -
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults
Mave, Vidya et al. | Date Issued: 2016 -
Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation
Erlandson, Kristine M et al. | Date Issued: 2017 -
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease
Périssé, André R. S. et al. | Date Issued: 2013 -
Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort
Rose, Rebecca et al. | Date Issued: 2018 -
Phylogenetic methods inconsistently predict the direction of HIV transmission among heterosexual pairs in the HPTN 052 cohort
Rose, Rebecca et al. | Date Issued: 2019 -
Pre-cART elevation of CRP and CD4+ T-Cell immune activation associated with HIV clinical progression in a multinational case-cohort study
Balagopal, Ashwin et al. | Date Issued: 2015 -
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
Salata, Robert A. et al. | Date Issued: 2023 -
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Cohen, Myron S. et al. | Date Issued: 2011 -
Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial
Safren, Steven A. et al. | Date Issued: 2014 -
A randomized comparison of anthropomorphic changes with preferred and alternative efavirenz-based antiretroviral regimens in diverse multinational Settings
Erlandson, Kristine M. et al. | Date Issued: 2015 -
Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003)
Swindells, Susan et al. | Date Issued: 2018 -
Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients: Week 48 Results of the ARIEL Trial
Violari, Avy et al. | Date Issued: 2015Background: ARIEL (Darunavir in treatment-experienced pediatric population) was a phase II, open-label study assessing safety and antiviral activity of darunavir/ritonavir twice daily with an optimized background ... -
Sex-related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation
Mathad, Jyoti S et al. | Date Issued: 2016 -
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
Grinsztejn, Beatriz et al. | Date Issued: 2019